朝聚眼科医疗控股有限公司（股票代码：02219）于2026年9月2日公告显示，当日公司在香港联交所场内回购18.55万股普通股，约占已发行股本的0.026%。本次回购最高价为每股2.515港元，最低价为每股2.46港元，总耗资约46.41万港元。
根据公告，上述股票回购基于2026年5月12日通过的购回授权，公司可购回股份总数为70,518,050股。截至目前，公司已累计回购4,509,000股，占授权通过当日已发行股本的0.639%。公告并披露，公司于2026年9月2日的已发行股本维持在701,460,000股，尚无库藏股，同时自该次回购起至2026年10月2日为新股或库藏股再出售的暂止期。
公司确认已遵守香港联交所证券上市规则及相关法例，本次回购事宜由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.